-
2024-515450-24-00
4
2022-04-22
Epithelial ovarian cancer
-
2024-512612-22-00
5
2021-12-09
Diabetic Foot Ulcer
-
2023-507164-39-00
6
2021-12-01
Induction of labour
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-511651-17-00
4
2021-09-21
Myelodysplastic syndrome
-
2024-514765-19-01
4
2021-08-12
Lynch syndrome, which is increasing the risk of developing colorectal
-
2024-512671-12-00
10
2021-03-05
Unresectable head and neck squamous cell carcinoma, metastatic head an
-
2022-501874-21-00
6
2020-12-15
Takotsubo syndrome
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-511053-22-00
4
2020-05-04
Primary sclerosing cholangitis (PSC)
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2024-517387-37-00
4
2019-12-12
Small abdominal aortic aneurysm (AAA) under active surveillance; 30-49
-
2023-508542-18-00
6
2019-09-02
Tonsilitis
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2023-504917-54-00
5
2018-10-30
Biochemical recurrence after prostate cancer surgery
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-517719-65-00
4
2017-02-01
Resectable pancreatic head cancer
-
2024-515626-92-00
4
2013-10-18
recurrent/progressive medulloblastoma, ependymoma and atypical teratoi
-
2024-518254-16-00
5
2013-03-01
Acute Myeloid Leukemia (Pediatric 0-18 years)
-
2024-513968-25-00
5
2025-04-28
Metastatic castration-resistant prostate cancer (mCRPC)
-
2024-517244-57-00
9
2025-03-03
Amyotrophic Lateral Sclerosis (ALS)
-
2024-518343-38-00
5
2025-02-12
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C